- Report
- July 2024
- 175 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Report
- October 2024
- 182 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- August 2024
- 182 Pages
Global
From €4218EUR$4,450USD£3,524GBP
- Report
- June 2024
- 185 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- July 2019
- 165 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- February 2024
- 117 Pages
North America
From €4502EUR$4,750USD£3,761GBP
- Report
- January 2024
- 150 Pages
Global
From €4597EUR$4,850USD£3,840GBP
- Report
- November 2023
- 182 Pages
Global
From €3411EUR$3,599USD£2,850GBP
Monensin is an animal pharmaceutical used in the livestock industry to improve feed efficiency and reduce feed costs. It is a type of ionophore, a class of antibiotics that are used to control coccidiosis, a parasitic disease that affects the digestive system of animals. Monensin is used in a variety of animal feed products, including poultry, swine, beef, and dairy. It is also used in pet food. Monensin is approved for use in the United States, Canada, and Europe.
Monensin is a widely used animal pharmaceutical, with a variety of applications in the livestock industry. It is used to improve feed efficiency and reduce feed costs, as well as to control coccidiosis. Monensin is approved for use in the United States, Canada, and Europe.
Some companies in the Monensin market include Elanco Animal Health, Merck Animal Health, Zoetis, and Bayer Animal Health. Show Less Read more
